S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment
Oct 2 2024
Length: 36 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wish list failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment

Listen for free

View show details

Summary
John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.

Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Show more Show less

Show more Show less

What listeners say about S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews

No reviews are available

Report a review on Amazon